Author Archives: FluidDA nv

FluidDA dans La Libre Belgique: towards a better management of lung cancer.

The European Respiratory Journal publishes a study performed by FluidDA demonstrating the value of functional imaging as a biomarker in COPD patients: Double blind, placebo controlled crossover study in COPD patients to assess the acute effect of budesonide/formoterol using multi-slice … Continue reading →

FluidDA publishes two articles in the International  Journal of Chronic Obstructive Pulmonary Disease The effects of long-term noninvasive ventilation in hypercapnic COPD patients: a randomized controlled pilot study. De Backer L, Vos W, Dieriks B, Daems D, Verhulst S, Vinchurkar … Continue reading →

At ERS 2011, FluidDA will present the results of a pilot study where new imaging tools are used to assess a new treatment for sleep apnea: hypoglossal nerve stimulation. This is a promising device that stimulates the tongue muscle during … Continue reading →

FluidDA’s CTO, Wim Vos, was awarded a “Noninvasive Ventilation Grant” by ERS and Resmed Inc for the innovative work in the field of imaging in COPD patients.

EPO grants patent to FluidDA on a “Method for determining treatments using patient-specific lung models and computer methods”